McN5652
McN5652 is a molecule that can be radiolabeled and then used as a radioligand in positron emission tomography (PET) studies. The [11C](+)McN5652 enantiomer binds to the serotonin transporter.[1]
WikiDoc Resources for McN5652 |
Articles |
---|
Most recent articles on McN5652 |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on McN5652 at Clinical Trials.gov Clinical Trials on McN5652 at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on McN5652
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating McN5652 Risk calculators and risk factors for McN5652
|
Healthcare Provider Resources |
Causes & Risk Factors for McN5652 |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
The radioligand is used for molecular neuroimaging, but also for imaging of the lungs.[2]
See also
References
- ↑ M. Suehiro, U. Scheffel, H. T. Ravert, R. F. Dannals & H. N. Jr Wagner (1993). "[11C](+)McN5652 as a radiotracer for imaging serotonin uptake sites with PET". Life Sciences. 53 (11): 883–882. doi:10.1016/0024-3205(93)90440-E. PMID 8366755.
- ↑ Akihiro Takano, Hiroshi Ito, Yasuhiko Sudo, Makoto Inoue, Tetsuya Ichimiya, Fumihiko Yasuno, Kazutoshi Suzuki & Tetsuya Suhara (2007). "Effects of smoking on the lung accumulation of [11C]McN5652". Annals of Nuclear Medicine. 21 (6): 349–344. doi:10.1007/s12149-007-0031-1. PMID 17705015. Unknown parameter
|month=
ignored (help)